MarketsFN
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
Stocks

company_name (CPB) ticker CPB Financial Results Summary

QuoteReporter

•3 min read
company_name (CPB) ticker CPB Financial Results Summary

Campbell's Company (CPB) Q4 2026: Significant Decline in Sales and Earnings — Disappointing Quarter

In the fourth quarter of fiscal 2026, Campbell's Company reported a notable decline in performance compared to the previous year. Net sales decreased by $184 million, or 8%, to $2.1 billion, while adjusted earnings per share (EPS) fell by 37% to $0.39. This stark drop in both revenue and earnings signals a disappointing quarter for shareholders.

Key Financial Metrics:

  • Net Sales: $2.1 billion, down $184 million or -8% YoY
  • Adjusted EPS: $0.39, down $0.23 or -37% YoY
  • EBIT: $4 million, down $265 million or -98% YoY
  • Adjusted EBIT: $242 million, down $79 million or -25% YoY
  • Organic Net Sales: Decreased 1% YoY

Analyst View:

This quarter's results are disappointing for shareholders, primarily due to the significant declines in both revenue and earnings. The company faced inflation-driven margin pressures and a decrease in volume/mix, which contributed to the overall decline. The reported loss of $0.23 per share, compared to earnings of $0.48 per share in the prior year, further emphasizes the challenges Campbell's is currently facing.

The company also announced a reset of its dividend, reducing it by 36% to $0.25 per share, which reflects a strategic move to accelerate debt reduction. This decision may be viewed negatively by income-focused investors but is necessary for improving the company's financial health.

Additional Highlights:

  • Full-Year Results: For the full fiscal year 2026, net sales decreased by 5% to $9.7 billion, and adjusted EPS fell by 27% to $2.17.
  • Cost Savings Initiatives: Campbell's is targeting $500 million in cost savings by fiscal 2030, with approximately $225 million already achieved under a previous program.
  • Cash Flow: Cash flow from operations was $1.0 billion, down from $1.1 billion in the prior year.

Forward-Looking Guidance:

Looking ahead, Campbell's has provided guidance for fiscal 2027, expecting net sales to decline between 4% to 2% and adjusted EPS to fall between $1.65 to $1.80. Investors should closely monitor the company's ability to execute its cost-saving initiatives and the impact of inflation on margins. Additionally, the performance of the newly acquired La Regina brand will be crucial in assessing future growth potential.

In summary, Campbell's fourth quarter results reflect significant challenges, and while the company is taking steps to address its financial position, the immediate outlook remains cautious. Investors should watch for updates on cost-saving measures and any changes in consumer demand that could influence future performance.

Note: All amounts in the following tables are in millions.

Three Months August 2, 2026 August 3, 2025
Net sales $2,137 $2,321
Costs and expenses
Cost of products sold $1,554 $1,616
Marketing and selling expenses $188 $202
Administrative expenses $164 $172
Research and development expenses $28 $26
Other expenses / (income) $147 $29
Restructuring charges $52 $7
Total costs and expenses $2,133 $2,052
Earnings before interest and taxes $4 $269
Interest, net $83 $85
Earnings (loss) before taxes $-79 $184
Taxes on earnings (loss) $-21 $39
Net earnings (loss) $-58 $145
Less: Net earnings (loss) attributable to noncontrolling interests $2 $—
Net earnings (loss) attributable to The Campbell's Company $-60 $145
Less: Accretion of redeemable noncontrolling interests $5 $—
Net earnings (loss) attributable to The Campbell's Company common shareholders - Basic $-65 $145
Less: Unrecognized accretion on deferred consideration $4 $—
Net earnings (loss) attributable to The Campbell's Company common shareholders - Diluted $-69 $145
Diluted Earnings (loss) per share attributable to The Campbell's Company common shareholders - Basic $-.22 $.49
Diluted Earnings (loss) per share attributable to The Campbell's Company common shareholders - Diluted $-.23 $.48
Weighted average shares outstanding - Basic 298 298
Weighted average shares outstanding - Diluted 304 299
August 2, 2026 August 3, 2025
Current assets
Cash and cash equivalents $394 $132
Accounts receivable $578 $583
Inventories $1,612 $1,424
Other current assets $136 $93
Total current assets $2,720 $2,232
Plant assets, net of depreciation $2,868 $2,767
Goodwill $5,321 $4,991
Other intangible assets, net of amortization $4,198 $4,356
Other assets $541 $550
Total assets $15,648 $14,896
Current liabilities
Short-term borrowings $977 $762
Accounts payable $1,377 $1,332
Accrued liabilities $860 $688
Dividends payable $118 $120
Accrued income taxes $4 $4
Total current liabilities $3,336 $2,906
Long-term debt $6,160 $6,095
Deferred taxes $1,393 $1,353
Other liabilities $603 $638
Total liabilities $11,492 $10,992
Commitments and contingencies
Redeemable noncontrolling interests $304 $—
The Campbell's Company shareholders' equity
Preferred stock; authorized 40 shares; none issued $— $—
Capital stock, $0.0375 par value; authorized 560 shares; issued 323 shares $12 $12
Additional paid-in capital $412 $418
Earnings retained in the business $4,620 $4,694
Capital stock in treasury, at cost $-1,182 $-1,207
Accumulated other comprehensive loss $-12 $-15
Total The Campbell's Company shareholders' equity $3,850 $3,902
Noncontrolling interests $2 $2
Total equity $3,852 $3,904
Total liabilities, redeemable noncontrolling interests and equity $15,648 $14,896

Disclaimer

The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.

Related Articles

Nasdaq 100 Bull & Bear Radar — October 02, 2026
Trending
Stocks

Nasdaq 100 Bull & Bear Radar — October 02, 2026

QuoteReporter
5 minOct 2, 2026
S&P 500 Bull & Bear Radar — October 02, 2026
Trending
Stocks

S&P 500 Bull & Bear Radar — October 02, 2026

QuoteReporter
5 minOct 2, 2026
Nasdaq 100 52-Week Highs & Lows Radar: NVIDIA (NVDA), Netflix (NFLX) and more
Stocks

Nasdaq 100 52-Week Highs & Lows Radar: NVIDIA (NVDA), Netflix (NFLX) and more

MarketsFN Team
6 minOct 2, 2026